DE3376957D1 - Pharmaceutical gel composition - Google Patents

Pharmaceutical gel composition

Info

Publication number
DE3376957D1
DE3376957D1 DE8383901885T DE3376957T DE3376957D1 DE 3376957 D1 DE3376957 D1 DE 3376957D1 DE 8383901885 T DE8383901885 T DE 8383901885T DE 3376957 T DE3376957 T DE 3376957T DE 3376957 D1 DE3376957 D1 DE 3376957D1
Authority
DE
Germany
Prior art keywords
gel composition
pharmaceutical gel
pharmaceutical
composition
gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383901885T
Other languages
German (de)
English (en)
Inventor
Robert Alan Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE3376957D1 publication Critical patent/DE3376957D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8383901885T 1982-06-24 1983-06-21 Pharmaceutical gel composition Expired DE3376957D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPF458382 1982-06-24
PCT/AU1983/000081 WO1984000111A1 (en) 1982-06-24 1983-06-21 Pharmaceutical gel composition

Publications (1)

Publication Number Publication Date
DE3376957D1 true DE3376957D1 (en) 1988-07-14

Family

ID=3769605

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383901885T Expired DE3376957D1 (en) 1982-06-24 1983-06-21 Pharmaceutical gel composition

Country Status (6)

Country Link
US (1) US4604384A (enExample)
EP (1) EP0112852B1 (enExample)
JP (1) JPS59501159A (enExample)
DE (1) DE3376957D1 (enExample)
MY (1) MY102101A (enExample)
WO (1) WO1984000111A1 (enExample)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0161681A3 (en) * 1984-05-17 1987-04-29 Mitsubishi Acetate Co., Ltd. Gel plate and process for preparing same
GB8530796D0 (en) * 1985-12-13 1986-01-22 Beecham Group Plc Pharmaceutical composition
DE3614095A1 (de) * 1986-04-25 1987-10-29 Goedecke Ag Oxyalkylcellulose enthaltende gelzubereitung
JPH021988A (ja) * 1987-12-03 1990-01-08 Texas Instr Inc <Ti> 電気的にプログラム可能なメモリ・セル
US5364622A (en) * 1987-12-04 1994-11-15 Dr. Karl Thomae Gmbh Methods for preventing adhesions to organs and parts of organs by application of tissue plasminogen activator and hydroxyethylcellulose hydrogel
DE3741149A1 (de) * 1987-12-04 1989-06-15 Thomae Gmbh Dr K Zubereitungsformen zur verhinderung von adhaesionen von organen und organteilen
US5002938A (en) * 1988-03-21 1991-03-26 Bristol-Myers Squibb Company Antifungal gel formulations
US5110809A (en) * 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
DE3903672C1 (enExample) * 1989-02-08 1990-02-01 Lohmann Gmbh & Co Kg
US5271943A (en) 1989-10-27 1993-12-21 Scott Health Care Wound gel compositions containing sodium chloride and method of using them
AU643058B2 (en) * 1990-08-30 1993-11-04 Terumo Kabushiki Kaisha Wound-covering materials
GB9105995D0 (en) * 1991-03-21 1991-05-08 Smith & Nephew Wound dressing
US5662924A (en) * 1991-03-21 1997-09-02 Smith & Nephew Plc Wound dressing
GB2276819B (en) * 1993-03-23 1996-12-11 Johnson & Johnson Medical Aqueous wound treatment composition comprising a polysaccharide and hexylene glycol
AU703926B2 (en) * 1994-03-28 1999-04-01 Trustees Of Columbia University In The City Of New York, The Composition for inactivating irritants in fluids
GB2291348B (en) 1994-07-18 1999-01-20 Johnson & Johnson Medical Sterile gel composition for wound treatment comprising alginate and polyhydric alcohol
CN1070626C (zh) * 1994-09-01 2001-09-05 赵庆杞 微机中央信号装置
GB9422571D0 (en) 1994-11-09 1995-01-04 Whitehall Lab Ltd Haemorrihoidal compositions and method of use
GB2322864A (en) 1997-03-07 1998-09-09 Polybiomed Ltd Gel for application to the human or animal body
US5763412A (en) * 1997-04-08 1998-06-09 Becton Dickinson And Company Film-forming composition containing chlorhexidine gluconate
US6605751B1 (en) * 1997-11-14 2003-08-12 Acrymed Silver-containing compositions, devices and methods for making
FI974610A0 (fi) * 1997-12-23 1997-12-23 Leiras Oy Farmaceutiskt preparat i gelform
WO1999062552A1 (en) * 1998-06-03 1999-12-09 Hwa Seong Kim Adhesion / fixation / cooling remedies for burn and therapeutic method for relieving burn scar
DE60028415T2 (de) * 1999-12-30 2007-06-06 Acrymed, Portland Methode und zusammensetzungen für verbesserte abgabevorrichtungen
AUPQ647600A0 (en) * 2000-03-27 2000-04-20 Chiltern Pharmaceuticals Pty. Limited Pharmaceutical gel composition
RU2232575C2 (ru) * 2000-06-13 2004-07-20 Государственное образовательное учреждение высшего профессионального образования "Волгоградский государственный медицинский университет" Средство для лечения хронического эндометрита
FR2811671B1 (fr) * 2000-07-17 2003-02-28 Corneal Ind Hydrogel de polymere(s), resistant a la biodegration, preparation et utilisation a titre de support de regeneration tissulaire
US6846846B2 (en) * 2001-10-23 2005-01-25 The Trustees Of Columbia University In The City Of New York Gentle-acting skin disinfectants
US7879365B2 (en) * 2002-02-07 2011-02-01 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of dermal and mucosal irritation
AU2003216213B2 (en) * 2002-02-07 2008-10-02 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
US7745425B2 (en) * 2002-02-07 2010-06-29 The Trustees Of Columbia University In The City Of New York Non-irritating compositions containing zinc salts
US8486426B2 (en) 2002-07-29 2013-07-16 Kimberly-Clark Worldwide, Inc. Methods and compositions for treatment of dermal conditions
CN102309473A (zh) * 2003-07-17 2012-01-11 纽约市哥伦比亚大学托管会 含有季铵化合物及精油和/或精油成分的协同组合的抗微生物组合物
RU2273480C2 (ru) * 2003-12-08 2006-04-10 Закрытое Акционерное Общество "Нита-Фарм" Фармацевтическая композиция для лечения заболеваний микробной и паразитарной этиологии
NZ592438A (en) 2004-07-30 2012-11-30 Kimberly Clark Co Antimicrobial compositions of silver nanoparticles
US8361553B2 (en) 2004-07-30 2013-01-29 Kimberly-Clark Worldwide, Inc. Methods and compositions for metal nanoparticle treated surfaces
CN102783499A (zh) * 2004-07-30 2012-11-21 金伯利-克拉克环球有限公司 抗微生物的装置和组合物
EP1809264B1 (en) * 2004-09-20 2016-04-13 Avent, Inc. Antimicrobial amorphous compositions
EP1666075A1 (en) * 2004-10-04 2006-06-07 Switch Biotech Aktiengesellschaft Wound dressing compositions, especially for delivery of protease inhibitors
CN1301106C (zh) * 2005-03-11 2007-02-21 广州贝氏药业有限公司 一种杀菌凝胶剂
DE102005045145A1 (de) * 2005-09-15 2007-03-29 Schülke & Mayr GmbH Verwendung von Octenidindihydrochlorid in halbfesten Zubereitungen
US7759327B2 (en) * 2006-01-06 2010-07-20 The Trustees Of Columbia University In The City Of New York Compositions containing zinc salts for coating medical articles
EP2015722B1 (en) * 2006-04-28 2016-11-16 Avent, Inc. Antimicrobial site dressings
US20080108674A1 (en) * 2006-05-01 2008-05-08 Enturia, Inc. Cationic antiseptic and dye formulation
US20070254854A1 (en) * 2006-05-01 2007-11-01 Medi-Flex, Inc. Aqueous Antiseptic Solution and Compatible Anionic Dye for Staining Skin
US20070253909A1 (en) * 2006-05-01 2007-11-01 Medi-Flex, Inc. Aqueous Antiseptic Solution and Compatible Cationic Dye for Staining Skin
JP5238295B2 (ja) * 2007-03-09 2013-07-17 第一三共ヘルスケア株式会社 低刺激性透明半固形外用剤
US20090087468A1 (en) * 2007-03-28 2009-04-02 Serena Stephenson Semi-Rigid Gel Article For Disinfecting A Surface
CN102065849B (zh) 2008-04-24 2015-04-29 麦德托尼克公司 基于壳聚糖和氧化多糖的保护性凝胶
WO2009132226A1 (en) * 2008-04-24 2009-10-29 Medtronic, Inc. Thiolated chitosan gel
CA2722155C (en) * 2008-04-24 2019-07-30 Medtronic, Inc. Cold ionizing radiation sterilization
EP2291524A2 (en) * 2008-04-24 2011-03-09 Medtronic, Inc Rehydratable thiolated polysaccharide particles and sponge
CA2721938C (en) * 2008-04-24 2016-08-09 Medtronic, Inc. Chitosan-containing protective composition
JP5722782B2 (ja) 2008-09-26 2015-05-27 ナノバイオ コーポレーション ナノエマルジョン治療用組成物及びその使用方法
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US20160346315A1 (en) * 2014-02-12 2016-12-01 University Of Southern California Methods for promoting wound healing
US20170202850A1 (en) * 2014-07-21 2017-07-20 Hiroaki Serizawa Ophthalmic compositions of rifamycins and uses thereof
WO2019147674A1 (en) * 2018-01-24 2019-08-01 Microtek Laboratories, Inc. Water based thermal cooling gels comprising a viscosity modifier and ice nucleating protein

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7307072A (enExample) * 1972-06-09 1973-12-11
DK137946B (da) * 1973-12-17 1978-06-12 Merck & Co Inc Bæremedium i fast form til anvendelse i ophthalmiske præparater.
AU7776275A (en) * 1974-04-11 1976-08-05 Warner Lambert Co Production of base for topical steroids
US4131677A (en) * 1975-05-02 1978-12-26 Merck & Co., Inc. Anti-inflammatory oxazolo [5,4-b]pyridines
JPS5381616A (en) * 1976-12-27 1978-07-19 Kowa Co Production of antiinflammatory and anodyne ointment
US4360518A (en) * 1979-08-06 1982-11-23 Johnson & Johnson Topical anti-inflammatory drug therapy
DE2951319C2 (de) * 1979-12-20 1983-12-22 Beiersdorf Ag, 2000 Hamburg Paste für medizinische Zwecke
GB2075837B (en) * 1980-05-14 1984-03-14 Hisamitsu Pharmaceutical Co Topical pharmaceutical gel containing anti-inflammatory analgesic agents
FR2489145A1 (fr) * 1980-09-04 1982-03-05 Geistlich Soehne Ag Compositions pharmaceutiques accelerant la guerison de blessures
DE3150402A1 (de) * 1980-12-29 1982-07-08 Colgate-Palmolive Co., 10022 New York, N.Y. Schnelltrocknende, bestaendige pulversuspension

Also Published As

Publication number Publication date
JPH0533204B2 (enExample) 1993-05-19
EP0112852A4 (en) 1985-04-11
EP0112852B1 (en) 1988-06-08
MY102101A (en) 1992-03-31
US4604384A (en) 1986-08-05
WO1984000111A1 (en) 1984-01-19
EP0112852A1 (en) 1984-07-11
JPS59501159A (ja) 1984-07-05

Similar Documents

Publication Publication Date Title
DE3376957D1 (en) Pharmaceutical gel composition
GB8326565D0 (en) Pharmaceutical compositions
GB8327612D0 (en) Pharmaceutical compositions
EP0138029A3 (en) Pharmaceutical composition
ZA834074B (en) Pharmaceutical composition
ZA833781B (en) Pharmaceutical compositions
EP0093551A3 (en) Pharmaceutical composition
GB2118176B (en) Pharmaceutical compositions
PT77323A (en) Pharmaceutical compositions
GB2117766B (en) Pharmaceutical compositions
GB8429749D0 (en) Pharmaceutical compositions
GB8313814D0 (en) Pharmaceutical compositions
GB8329700D0 (en) Anti-haemophilic pharmaceutical composition
GB8328896D0 (en) Pharmaceutical composition
DE3377696D1 (en) Pharmaceutical compositions
US4594359B1 (en) Pharmaceutical compositions
GB2114001B (en) Nasel pharmaceutical compositions
DE3176849D1 (en) Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate
GB8305028D0 (en) Pharmaceutical compositions
GB8332653D0 (en) Pharmaceutical composition
GB8330810D0 (en) Pharmaceutical compositions
GB8314736D0 (en) Pharmaceutical compositions
AU1603683A (en) Pharmaceutical gel composition
GB8331068D0 (en) Pharmaceutical compositions
GB8314540D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
8364 No opposition during term of opposition